These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 38886396)
1. C-terminally phosphorylated p27 activates self-renewal driver genes to program cancer stem cell expansion, mammary hyperplasia and cancer. Razavipour SF; Yoon H; Jang K; Kim M; Nawara HM; Bagheri A; Huang WC; Shin M; Zhao D; Zhou Z; Van Boven D; Briegel K; Morey L; Ince TA; Johnson M; Slingerland JM Nat Commun; 2024 Jun; 15(1):5152. PubMed ID: 38886396 [TBL] [Abstract][Full Text] [Related]
2. p27 transcriptionally coregulates cJun to drive programs of tumor progression. Yoon H; Kim M; Jang K; Shin M; Besser A; Xiao X; Zhao D; Wander SA; Briegel K; Morey L; Minn A; Slingerland JM Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7005-7014. PubMed ID: 30877256 [TBL] [Abstract][Full Text] [Related]
3. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2. Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964 [TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation. Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140 [TBL] [Abstract][Full Text] [Related]
5. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway. Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039 [TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation. Al-Dhfyan A; Alhoshani A; Korashy HM Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884 [TBL] [Abstract][Full Text] [Related]
8. Mammary stem cells and breast cancer--role of Notch signalling. Farnie G; Clarke RB Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349 [TBL] [Abstract][Full Text] [Related]
9. Atypical cell cycle regulation promotes mammary stem cell expansion during mammary development and tumourigenesis. Fifield BA; Vusich J; Haberfellner E; Andrechek ER; Porter LA Breast Cancer Res; 2024 Jun; 26(1):106. PubMed ID: 38943151 [TBL] [Abstract][Full Text] [Related]
10. JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance. Wang T; Fahrmann JF; Lee H; Li YJ; Tripathi SC; Yue C; Zhang C; Lifshitz V; Song J; Yuan Y; Somlo G; Jandial R; Ann D; Hanash S; Jove R; Yu H Cell Metab; 2018 Jan; 27(1):136-150.e5. PubMed ID: 29249690 [TBL] [Abstract][Full Text] [Related]
11. s-SHIP Promoter Expression Identifies Mouse Mammary Cancer Stem Cells. Tian L; Truong MJ; Lagadec C; Adriaenssens E; Bouchaert E; Bauderlique-Le Roy H; Figeac M; Le Bourhis X; Bourette RP Stem Cell Reports; 2019 Jul; 13(1):10-20. PubMed ID: 31204299 [TBL] [Abstract][Full Text] [Related]
12. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK. Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922 [TBL] [Abstract][Full Text] [Related]
13. The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment. Albino D; Civenni G; Rossi S; Mitra A; Catapano CV; Carbone GM Oncotarget; 2016 Nov; 7(47):76756-76768. PubMed ID: 27732936 [TBL] [Abstract][Full Text] [Related]
14. p63 Sustains self-renewal of mammary cancer stem cells through regulation of Sonic Hedgehog signaling. Memmi EM; Sanarico AG; Giacobbe A; Peschiaroli A; Frezza V; Cicalese A; Pisati F; Tosoni D; Zhou H; Tonon G; Antonov A; Melino G; Pelicci PG; Bernassola F Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3499-504. PubMed ID: 25739959 [TBL] [Abstract][Full Text] [Related]
15. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis. Celià-Terrassa T; Liu DD; Choudhury A; Hang X; Wei Y; Zamalloa J; Alfaro-Aco R; Chakrabarti R; Jiang YZ; Koh BI; Smith HA; DeCoste C; Li JJ; Shao ZM; Kang Y Nat Cell Biol; 2017 Jun; 19(6):711-723. PubMed ID: 28530657 [TBL] [Abstract][Full Text] [Related]
16. PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma. Cortez V; Samayoa C; Zamora A; Martinez L; Tekmal RR; Vadlamudi RK Cancer Res; 2014 Dec; 74(24):7395-405. PubMed ID: 25377474 [TBL] [Abstract][Full Text] [Related]